PUBLISHER: Value Market Research | PRODUCT CODE: 1346810
PUBLISHER: Value Market Research | PRODUCT CODE: 1346810
Global Oxycodone Hydrochloride Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
The global demand for Oxycodone Hydrochloride Market is presumed to reach the market size of nearly USD 612.65 MN by 2030 from USD 406.23 MN in 2022 with a CAGR of 5.27% under the study period 2023 - 2030.
Oxycodone hydrochloride is a powerful opioid analgesic medication used to manage moderate to severe pain. It belongs to the class of medications known as opioid agonists. It is available in various formulations, including immediate-release and extended-release versions, to provide pain relief over different time periods.
MARKET DYNAMICS:
The growth of the oxycodone hydrochloride market is influenced by several factors. It is primarily driven by the increasing need for effective pain management in cases of moderate to severe pain, such as after medical procedures, surgeries, trauma, injury, and cancer-related pain. The aging global population and the prevalence of chronic pain conditions contribute to the rising demand. Medical professionals' prescription practices, healthcare infrastructure, and awareness about pain management options impact its utilization. Regulatory frameworks, pharmaceutical industry dynamics, and guidelines for opioid prescription also play a role. The market's evolution must be understood in the context of the ongoing efforts to balance pain relief needs with the associated risks and challenges. Staying informed through reliable medical sources is essential for understanding the current state of the oxycodone hydrochloride market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oxycodone hydrochloride. The growth and trends of oxycodone hydrochloride industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the oxycodone hydrochloride market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Controlled-Release
- Immediate-Release
By Route Of Administration
- Oral
- Parenteral
By Distribution Channel
- Hospitals
- Retail Pharmacies
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Oxycodone Hydrochloride market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oxycodone Hydrochloride market include Eli Lilly and Co., Gilead Sciences Inc., Manus Aktteva Biopharma LLP, Arevipharma, Saneca Pharma, Cipla Ltd, Noramco, Macfarian Smith, Teva Pharmaceutical Industries Ltd, Taj Pharma, Chattem Chemicals Inc., Mayne Pharma Group Limited, Dr. Reddy's Laboratories Ltd, Siegfried, Rhodes Pharmaceuticals, Mallinckrodt Plc, Johnson & Johnson, Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd, Lupin Ltd, and Sanofi Sais. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . OXYCODONE HYDROCHLORIDE - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY TYPE
- 5.1 Overview by Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Type
- 5.4 Controlled-Release Historic and Forecast Sales by Regions
- 5.5 Immediate-Release Historic and Forecast Sales by Regions
6 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- 6.1 Overview by Route of Administration
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Route of Administration
- 6.4 Oral Historic and Forecast Sales by Regions
- 6.5 Parenteral Historic and Forecast Sales by Regions
7 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 7.1 Overview by Distribution Channel
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Distribution Channel
- 7.4 Hospitals Historic and Forecast Sales by Regions
- 7.5 Retail Pharmacies Historic and Forecast Sales by Regions
8 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE OXYCODONE HYDROCHLORIDE COMPANIES
- 9.1. Oxycodone Hydrochloride Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF OXYCODONE HYDROCHLORIDE INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Eli Lilly and Co.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Gilead Sciences Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Manus Aktteva Biopharma LLP
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Arevipharma
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Saneca Pharma
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Cipla Ltd
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Noramco
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Macfarian Smith
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Teva Pharmaceutical Industries Ltd
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Taj Pharma
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
- 10.13. Chattem Chemicals Inc.
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
- 10.14. Mayne Pharma Group Limited
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
- 10.15. Dr. Reddy's Laboratories Ltd
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
- 10.16. Siegfried
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments
- 10.17. Rhodes Pharmaceuticals
- 10.17.1. Company Overview
- 10.17.2. Company Revenue
- 10.17.3. Products
- 10.17.4. Recent Developments
- 10.18. Mallinckrodt Plc
- 10.18.1. Company Overview
- 10.18.2. Company Revenue
- 10.18.3. Products
- 10.18.4. Recent Developments
- 10.19. Johnson & Johnson
- 10.19.1. Company Overview
- 10.19.2. Company Revenue
- 10.19.3. Products
- 10.19.4. Recent Developments
- 10.20. Bristol-Myers Squibb Company
- 10.20.1. Company Overview
- 10.20.2. Company Revenue
- 10.20.3. Products
- 10.20.4. Recent Developments
- 10.21. Sun Pharmaceutical Industries Ltd
- 10.21.1. Company Overview
- 10.21.2. Company Revenue
- 10.21.3. Products
- 10.21.4. Recent Developments
- 10.22. Lupin Ltd
- 10.22.1. Company Overview
- 10.22.2. Company Revenue
- 10.22.3. Products
- 10.22.4. Recent Developments
- 10.23. Sanofi Sais
- 10.23.1. Company Overview
- 10.23.2. Company Revenue
- 10.23.3. Products
- 10.23.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Type (USD MN)
- Controlled-Release Market Sales by Geography (USD MN)
- Immediate-Release Market Sales by Geography (USD MN)
- Analysis Market by Route of Administration (USD MN)
- Oral Market Sales by Geography (USD MN)
- Parenteral Market Sales by Geography (USD MN)
- Analysis by Distribution Channel (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Global Oxycodone Hydrochloride Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Oxycodone Hydrochloride Report
- Market Research Process
- Market Research Methodology
- Global Oxycodone Hydrochloride Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Route of Administration
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- Controlled-Release Market Sales by Geography (USD MN)
- Immediate-Release Market Sales by Geography (USD MN)
- Global Market Analysis by Route of Administration (USD MN)
- Oral Market Sales by Geography (USD MN)
- Parenteral Market Sales by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
